Remove Access Remove Clinical Trials Remove Decriminalization Remove Patients
article thumbnail

DEA Faces Lawsuit For Denying End of Life Patients the Right to Try Psychedelics Therapy

Veriheal

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 55
article thumbnail

A Moral COMPASS to Treat Mental Health Disorders Using the Magic of Psilocybin

NewsMunchies

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Decriminalized Decriminalization does not mean psilocybin is legal.

article thumbnail

The “Right to Try” Psilocybin and New Drug Therapies

Canna Law Blog

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 81
article thumbnail

The Medical Marijuana and Cannabidiol Research Expansion Act Has Passed

Veriheal

The bill further states that it “shall not be a violation of the Controlled Substances Act (CSA) for a State-licensed physician to discuss” the risk and benefits of marijuana and cannabis-derived products with patients. Rescheduling cannabis and decriminalizing cannabis do not mean the same thing for federal legalization.

article thumbnail

Weekly Legislative Roundup 1/4/19

NORML

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. NH resident? GA resident?

article thumbnail

Weekly Legislative Roundup 1/18/19

NORML

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.